跳至主要内容
临床试验/NCT04711746
NCT04711746招募中不适用

Is Clonal Hematopoiesis of Indeterminate Potential Associated With Unprovoked Pulmonary Embolism?

Centre Hospitalier Universitaire, Amiens1 个研究点 分布在 1 个国家目标入组 544 人开始时间: 2021年2月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
招募中
入组人数
544
试验地点
1
主要终点
Variation of CHIP markers between patients groups

研究概览

简要总结

The clonal hematopoiesis of indetermined prognosis (CHIP) has been described as risk factor for juvenile atherosclerosis. Moreover, some of CHIP genes are responsible of myeloproliferative disorders. Venous thrombosis are frequent in these disorders. The purpose of this project is to determine if CHIP is frequent in unprovoked pulmonary embolism and could be part of the pathophysiology.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • For cases : Previous proximal unprovoked pulmonary embolism, negative thrombophilia screening.
  • For control : Previous proximal provoked pulmonary embolism, negative thrombophilia screening.

排除标准

  • Age superior to 65 years old,
  • Active cancer

研究组 & 干预措施

Previous proximal unprovoked pulmonary embolism

Experimental

干预措施: blood sample (Biological)

Previous proximal provoked pulmonary embolism

Active Comparator

干预措施: blood sample (Biological)

结局指标

主要结局

Variation of CHIP markers between patients groups

时间窗: up to 2 years

Variation of CHIP markers (clonal hematopoiesis of indetermined prognosis ) between patients groups. CHIP concept have been defined as a mutation of preleukemic genes at an allelic variation inferior to 2% associated with normal complete blood count.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验